aerpio therapeutics: focus on tie2 activation (ois@asrs 2016)
Published 8 years ago • 337 plays • Length 8:04Download video MP4
Download video MP3
Similar videos
-
7:09
aerpio’s unique approach to activating tie2 (ois@aao 2016)
-
4:24
allegro ophthalmics: first-in-class anti-integrin agent (ois@asrs 2016)
-
5:45
pfenex moves forward with lucentis biosimilar (ois@asrs 2016)
-
7:45
opthea: targeting a more complete blockade of vegf (ois@asrs 2016)
-
22:20
retina experts serve up a combination platter at ois@asrs (ois@asrs 2016)
-
28:31
ois podcast ep #386: quick takes from ophthalmology start-ups
-
30:01
ois podcast ep #402: venture insights on retinal innovation
-
31:45
future of retina innovation
-
6:56
ocular therapeutix: intravitreal depot technology for retinal drug delivery (ois@asrs 2016)
-
7:04
truevision adds alcon as digital microscope partner (ois@asrs 2016)
-
8:06
ois co chair bill link wraps up ois@asrs (ois@asrs 2016)
-
7:59
welcome to ois@asrs 2016
-
6:28
graybug vision presentation on retinal drug delivery solutions at ois@asrs 2019
-
6:05
alimera sciences: addressing dme with persistent microdose therapy (ois@asrs 2016)
-
16:28
ora’s shapiro on the pursuit of retina’s “holy grail” (ois@asrs 2016)
-
8:36
genentech’s adamis speaks on ophthalmology’s importance and a professional hero (ois@asrs 2016)
-
5:59
regeneron: pursuing combination therapies with pdgfr-beta and ang2 (ois@asrs 2016)
-
9:01
aerie pharmaceuticals - public company showcase at ophthalmology innovation summit @ asrs 2019
-
7:57
aerpio looks to take lead agent beyond dr
-
17:17
what were the highlights of ois@asrs?